MC1R r等位基因不增加MITF E318K携带者的黑色素瘤风险
研究汇总五个澳大利亚和两个欧洲研究队列的1165例MITF E318K-和322例E318K+个体的黑色素瘤状态与MC1R基因型数据,发现RHC等位基因/基因型在E318K-和E318K+个体中对黑色素瘤风险的影响不同:在E318K-个体中所有RHC等位基因均增加风险,而在E318K+个体中仅MC1R R增加风险,r等位基因风险与野生型相当。UK Biobank 20万外显子数据支持该发现。
要点
- 在MITF E318K-个体中,MC1R R和r等位基因均增加黑色素瘤风险(P<0.001)。
- 在MITF E318K+个体中,R等位基因增加风险(OR 2.04,95%CI 1.67-2.49;P=0.01),r等位基因风险与野生型相当(OR 0.78,95%CI 0.54-1.14)。
- E318K+个体中R基因型(R/R、R/r、R/wt)风险显著高于非R基因型(r/r、r/wt、wt/wt)(P<0.001)。
核心结论
- RHC等位基因/基因型在MITF E318K-和E318K+个体中对黑色素瘤风险的影响不同。
- 在E318K-个体中所有RHC等位基因相对野生型均增加风险,但在E318K+个体中仅MC1R R增加风险。
- 在E318K+队列中MC1R r等位基因风险与野生型相当。
- 这些发现可为MITF E318K+个体的咨询和管理提供信息。
研究设计与样本
- 研究汇总五个澳大利亚和两个欧洲研究队列的黑色素瘤状态与MC1R、MITF E318K基因型数据。
- 另从数据库提取E318K+伴或不伴黑色素瘤个体的RHC基因型。
- 使用χ2检验和逻辑回归分析E318K+/-队列中RHC等位基因和基因型频率与黑色素瘤状态的关系。
- 在UK Biobank 20万一般人群外显子数据中进行重复分析。
- 队列共包含1165例MITF E318K-和322例E318K+个体。
主要发现
- 在E318K-病例中,MC1R R和r等位基因相对野生型均增加黑色素瘤风险,P<0.001。
- 在E318K-病例中,每种MC1R RHC基因型(R/R、R/r、R/wt、r/r和r/wt)相对wt/wt均增加黑色素瘤风险(P<0.001)。
- 在E318K+病例中,R等位基因相对wt等位基因增加黑色素瘤风险(OR 2.04,95%CI 1.67-2.49;P=0.01)。
- 在E318K+病例中,r等位基因风险与wt等位基因相当(OR 0.78,95%CI 0.54-1.14 vs. 1.00)。
- E318K+病例中r/r基因型相对wt/wt的黑色素瘤风险较低但未达统计学显著(OR 0.52,95%CI 0.20-1.38)。
临床怎么用
- 作者认为这些发现可为MITF E318K+个体的咨询和管理提供信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Population-wide screening for melanoma is not cost-effective, but genetic characterization could facilitate risk stratification and targeted screening. Common Melanocortin-1 receptor (MC1R) red hair colour (RHC) variants and Microphthalmia-associated transcription factor (MITF) E318K separately confer moderate melanoma susceptibility, but their interactive effects are relatively unexplored. OBJECTIVES: To evaluate whether MC1R genotypes differentially affect melanoma risk in MITF E318K+ vs. E318K- individuals. MATERIALS AND METHODS: Melanoma status (affected or unaffected) and genotype data (MC1R and MITF E318K) were collated from research cohorts (five Australian and two European). In addition, RHC genotypes from E318K+ individuals with and without melanoma were extracted from databases (The Cancer Genome Atlas and Medical Genome Research Bank, respectively). χ2 and logistic regression were used to evaluate RHC allele and genotype frequencies within E318K+/- cohorts depending on melanoma status. Replication analysis was conducted on 200 000 general-population exomes (UK Biobank). RESULTS: The cohort comprised 1165 MITF E318K- and 322 E318K+ individuals. In E318K- cases MC1R R and r alleles increased melanoma risk relative to wild type (wt), P < 0.001 for both. Similarly, each MC1R RHC genotype (R/R, R/r, R/wt, r/r and r/wt) increased melanoma risk relative to wt/wt (P < 0.001 for all). In E318K+ cases, R alleles increased melanoma risk relative to the wt allele [odds ratio (OR) 2.04 (95% confidence interval 1.67-2.49); P = 0.01], while the r allele risk was comparable with the wt allele [OR 0.78 (0.54-1.14) vs. 1.00, respectively]. E318K+ cases with the r/r genotype had a lower but not significant melanoma risk relative to wt/wt [OR 0.52 (0.20-1.38)]. Within the E318K+ cohort, R genotypes (R/R, R/r and R/wt) conferred a significantly higher risk compared with non-R genotypes (r/r, r/wt and wt/wt) (P < 0.001). UK Biobank data supported our findings that r did not increase melanoma risk in E318K+ individuals. CONCLUSIONS: RHC alleles/genotypes modify melanoma risk differently in MITF E318K- and E318K+ individuals. Specifically, although all RHC alleles increase risk relative to wt in E318K- individuals, only MC1R R increases melanoma risk in E318K+ individuals. Importantly, in the E318K+ cohort the MC1R r allele risk is comparable with wt. These findings could inform counselling and management for MITF E318K+ individuals.
引用
- Wallingford CK, Demeshko A, Krishnakripa AK, et al. The MC1R r allele does not increase melanoma risk in MITF E318K carriers. Br J Dermatol. 2023. PMID: 36879448. doi:10.1093/bjd/ljad041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。